Ulrik Spork is active as Chairman, board member, and advisor in several emerging life-science and MedTech companies as well as two venture/PE funds-of-funds. For over 25 years Ulrik held senior positions in the Novo Group, where he effectively executed Novo Nordisk’s corporate development activities. He also founded and led as Senior/Managing Partner the Venture, Growth Equity, and Principal Investment activities in Novo Holdings A/S. He holds a master’s degree in engineering from DTU-Technical University of Denmark.
Current role